Evidence map›Paper›PMID 29759080›Full record

ArticleFluids and barriers of the CNS2018

Zika virus crosses an in vitro human blood brain barrier model.

Judie B Alimonti, Maria Ribecco-Lutkiewicz, Caroline Sodja, Anna Jezierski, Danica B Stanimirovic, Qing Liu, Arsalan S Haqqani, Wayne Conlan, Mahmud Bani-Yaghoub

Abstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. An Overview of Zika Virus and Zika Virus Induced Neuropathies.International journal of molecular sciences · 2024
    Review
  15. Group BJournal of bacteriology · 2024
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Current neuropharmacology · 2024
    Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Judie B AlimontiHuman Health Therapeutics Research Center, National Research Council of Canada, 100 Sussex Dr., Ottawa, ON, Canada.
Maria Ribecco-LutkiewiczHuman Health Therapeutics Research Center, National Research Council of Canada, Bldg M54-1200 Montreal Rd., Ottawa, ON, K1A 0R6, Canada.
Caroline SodjaHuman Health Therapeutics Research Center, National Research Council of Canada, Bldg M54-1200 Montreal Rd., Ottawa, ON, K1A 0R6, Canada.
Anna JezierskiHuman Health Therapeutics Research Center, National Research Council of Canada, Bldg M54-1200 Montreal Rd., Ottawa, ON, K1A 0R6, Canada. anna.jezierski@nrc-cnrc.gc.ca.ORCID http://orcid.org/0000-0002-0837-4678
Danica B StanimirovicHuman Health Therapeutics Research Center, National Research Council of Canada, Bldg M54-1200 Montreal Rd., Ottawa, ON, K1A 0R6, Canada.
Qing LiuHuman Health Therapeutics Research Center, National Research Council of Canada, Bldg M54-1200 Montreal Rd., Ottawa, ON, K1A 0R6, Canada.
Arsalan S HaqqaniHuman Health Therapeutics Research Center, National Research Council of Canada, 100 Sussex Dr., Ottawa, ON, Canada.
Wayne ConlanHuman Health Therapeutics Research Center, National Research Council of Canada, 100 Sussex Dr., Ottawa, ON, Canada.
Mahmud Bani-YaghoubHuman Health Therapeutics Research Center, National Research Council of Canada, Bldg M54-1200 Montreal Rd., Ottawa, ON, K1A 0R6, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zika virus (ZIKV) is a flavivirus that is highly neurotropic causing congenital abnormalities and neurological damage to the central nervous systems (CNS). In this study, we used a human induced pluripotent stem cell (iPSC)-derived blood brain barrier (BBB) model to demonstrate that ZIKV can infect brain endothelial cells (i-BECs) without compromising the BBB barrier integrity or permeability. Although no disruption to the BBB was observed post-infection, ZIKV particles were released on the abluminal side of the BBB model and infected underlying iPSC-derived neural progenitor cells (i-NPs). AXL, a putative ZIKV cellular entry receptor, was also highly expressed in ZIKV-susceptible i-BEC and i-NPs. This iPSC-derived BBB model can help elucidate the mechanism by which ZIKV can infect BECs, cross the BBB and gain access to the CNS.

Indexed as

Blood-Brain BarrierCapillary PermeabilityCell Culture TechniquesEndothelial CellsHumansInduced Pluripotent Stem CellsMicrovesselsZika VirusZika Virus InfectionAXLBlood–brain barrier modelBrain endothelial cellsiPSCNeural progenitorsZika virus

Identifiers

PMID29759080
PMCPMC5952854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.